Literature DB >> 15599576

[S2 Guideline for diagnosis and therapy of infectious endocarditis].

C K Naber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15599576     DOI： 10.1007/s00392-004-0183-0

Source DB:  PubMed          Journal:  Z Kardiol        ISSN： 0300-5860


× No keyword cloud information.
  93 in total

1.  Diagnosis of culture-negative endocarditis: the role of the Duke criteria and the impact of transesophageal echocardiography.

Authors:  L I Kupferwasser; H Darius; A M Müller; C Martin; S Mohr-Kahaly; R Erbel; J Meyer
Journal:  Am Heart J       Date:  2001-07       Impact factor: 4.749

2.  Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group.

Authors:  D J Sexton; M J Tenenbaum; W R Wilson; J M Steckelberg; A D Tice; D Gilbert; W Dismukes; R H Drew; D T Durack
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

3.  Successful two-week treatment schedule for penicillin-susceptible streptococcus viridans endocarditis.

Authors:  J S Tan; S Kaplan; C A Terhune; M Hamburger
Journal:  Lancet       Date:  1971-12-18       Impact factor: 79.321

4.  Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients.

Authors:  R G Nahass; M P Weinstein; J Bartels; D J Gocke
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

5.  Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study.

Authors:  R Choussat; D Thomas; R Isnard; P L Michel; B Iung; G Hanania; P Mathieu; M David; T du Roy de Chaumaray; G De Gevigney; H Le Breton; Y Logeais; E Pierre-Justin; C de Riberolles; Y Morvan; N Bischoff
Journal:  Eur Heart J       Date:  1999-02       Impact factor: 29.983

6.  Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy.

Authors:  P Tornos; B Almirante; S Mirabet; G Permanyer; A Pahissa; J Soler-Soler
Journal:  Arch Intern Med       Date:  1999-03-08

7.  Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.

Authors:  W R Wilson; C J Wilkowske; A J Wright; M A Sande; J E Geraci
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

8.  Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin.

Authors:  W R Wilson; R L Thompson; C J Wilkowske; J A Washington; E R Giuliani; J E Geraci
Journal:  JAMA       Date:  1981 Jan 23-30       Impact factor: 56.272

9.  Changing profile of infective endocarditis: results of a 1-year survey in France.

Authors:  Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

10.  Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.

Authors:  H F Chambers; O M Korzeniowski; M A Sande
Journal:  Medicine (Baltimore)       Date:  1983-05       Impact factor: 1.889
View more
  18 in total

Review 1.  [Infective endocarditis as cardiovascular emergency].

Authors:  B Plicht; R-A Jánosi; T Buck; R Erbel
Journal:  Internist (Berl)       Date:  2010-08       Impact factor: 0.743

Review 2.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

3.  A sequel of pacemaker infection.

Authors:  S Perl; R Maier; N Watzinger
Journal:  Clin Res Cardiol       Date:  2007-08-13       Impact factor: 5.460

4.  [Medical guideline for the treatment of adults with congenital heart abnormalities of the German-Austrian-Swiss Cardiology Specialty Society].

Authors:  A A Schmaltz; U Bauer; H Baumgartner; R Cesnjevar; F de Haan; C Franke; H Gabriel; C Gohlke-Bärwolf; S Hagl; J Hess; M Hofbeck; H Kaemmerer; H C Kallfelz; P E Lange; H Nock; E Oechslin; K R Schirmer; U Tebbe; P Trigo Trindade; M Weyand; G Breithardt
Journal:  Clin Res Cardiol       Date:  2008-03       Impact factor: 5.460

Review 5.  Heart valve surgery today: indications, operative technique, and selected aspects of postoperative care in acquired valvular heart disease.

Authors:  Hans Joachim Geissler; Christian Schlensak; Michael Südkamp; Friedhelm Beyersdorf
Journal:  Dtsch Arztebl Int       Date:  2009-03-27       Impact factor: 5.594

6.  [Surgical therapy of infective endocarditis].

Authors:  S M Tugtekin
Journal:  Z Kardiol       Date:  2005

7.  [Heart diseases in pregnancy].

Authors:  Vera Regitz-Zagrosek; Christa Gohlke-Bärwolf; Annette Geibel-Zehender; Markus Haass; Harald Kaemmerer; Irmtraut Kruck; Christoph Nienaber
Journal:  Clin Res Cardiol       Date:  2008-09       Impact factor: 5.460

8.  [ESC and AHA guidelines 2015 on endocarditis : In competition or synchrony?]

Authors:  Bernhard Maisch
Journal:  Herz       Date:  2016-12       Impact factor: 1.443

Review 9.  Regulation of food intake by oleoylethanolamide.

Authors:  J Lo Verme; S Gaetani; J Fu; F Oveisi; K Burton; D Piomelli
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

10.  Interactions between endocarditis-derived Streptococcus gallolyticus subsp. gallolyticus isolates and human endothelial cells.

Authors:  Tanja Vollmer; Dennis Hinse; Knut Kleesiek; Jens Dreier
Journal:  BMC Microbiol       Date:  2010-03-16       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.